ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

AMPE Ampio Pharmaceuticals Inc

0.62
0.00 (0.00%)
Last Updated: 19:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Ampio Pharmaceuticals Inc AMPE AMEX Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 0.62 19:00:00
Open Price Low Price High Price Close Price Previous Close
0.62
more quote information »

Recent News

Date Time Source Heading
4/03/202413:33PRNUSAmpio Pharmaceuticals Received Audit Opinion with Going..
3/25/202416:00PRNUSAmpio Announces Voluntary Delisting and SEC Deregistration
3/04/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
2/28/202414:49EDGAR2Form 8-K - Current report
2/28/202414:48EDGAR2Form S-8 POS - Securities to be offered to employees in..
2/28/202414:47EDGAR2Form S-8 POS - Securities to be offered to employees in..
2/28/202414:46EDGAR2Form POS AM - Post-Effective amendments for registration..
2/28/202414:45EDGAR2Form RW - Registration Withdrawal Request
2/15/202408:31EDGAR2Form 8-K - Current report
2/14/202416:45PRNUSAmpio Provides Update on Results from Pre-IND Enabling..
1/25/202415:31EDGAR2Form 8-K - Current report
1/25/202415:18EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
1/24/202416:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
1/11/202415:20EDGAR2Form 8-K - Current report
1/11/202415:15PRNUSAmpio Provides Litigation Update - Reports Settlement in..
12/21/202315:25EDGAR2Form S-1 - General form for registration of securities under..
11/14/202315:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/202308:30EDGAR2Form 8-K - Current report
10/31/202308:00PRNUSAmpio Pharmaceuticals to Present at the Emerging Growth..
10/27/202313:10EDGAR2Form 8-K - Current report
10/06/202313:56EDGAR2Form 8-K - Current report
10/05/202315:30PRNUSAmpio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO..
10/04/202315:15EDGAR2Form 8-K - Current report
9/26/202308:15PRNUSAmpio Pharmaceuticals to Present at the Emerging Growth..
9/22/202315:30EDGAR2Form 8-K - Current report
9/18/202315:30EDGAR2Form S-3 - Registration statement under Securities Act of..
8/31/202315:19EDGAR2Form 8-K - Current report
8/31/202305:30PRNUSAmpio Pharmaceuticals Announces Reverse Stock Split
8/15/202315:56EDGAR2Form S-8 - Securities to be offered to employees in employee..
8/08/202315:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/13/202310:33EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
7/05/202315:37EDGAR2Form 8-K - Current report
5/26/202315:40PRNUSAmpio Pharmaceuticals Announces Series D Preferred Stock..

Your Recent History

Delayed Upgrade Clock